Angola

Reimbursed Care Access

Angola is a party to the core UN drug‑control treaties and maintains a restrictive national approach to classical psychedelics and novel psychoactive substances; most classic psychedelics (psilocybin, MDMA, DMT, mescaline, 2C‑family, 5‑MeO‑DMT, ibogaine, ayahuasca) are controlled with no routine medical/reimbursement pathways outside approved research. Ketamine is widely recognized internationally as an essential anesthetic and is used in clinical settings in low‑ and middle‑income countries; there is no public evidence of an approved, reimbursed national program for esketamine (Spravato) for psychiatric indications in Angola. Angola is party to the UN psychotropics and narcotics conventions which require national controls on many of these substances. [https://treaties.un.org/Pages/ViewDetails.aspx?chapter=6&mtdsg_no=VI-17&src=IND|UN Treaty Collection] [https://treaties.un.org/Pages/ViewDetails.aspx?chapter=6&mtdsg_no=VI-15&src=TREATY|UN Treaty Collection]